Key Points
- Insider buying: Nick Keher purchased 69 Oxford Nanopore Technologies shares at GBX 215 each, worth £148.35. He has also made several purchases since August, including 15,325 shares acquired for £24,826.50.
- Stock and financial performance: Shares opened at GBX 208.60 and have traded between GBX 95.61 and GBX 238.80 over the past year. The company remains unprofitable, reporting a quarterly loss of GBX 4.90 per share and a negative net margin of 54.66%.
- Analyst view: Analysts maintain a generally positive outlook, with five Buy ratings and one Hold rating. MarketBeat reports a “Moderate Buy” consensus and an average price target of GBX 198.60.
Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Nick Keher bought 69 shares of Oxford Nanopore Technologies stock in a transaction on Wednesday, October 14th. The stock was acquired at an average price of GBX 215 per share, for a total transaction of £148.35.
Nick Keher also recently made the following trade(s):
- On Monday, September 14th, Nick Keher purchased 96 shares of Oxford Nanopore Technologies stock. The stock was acquired at an average cost of GBX 157 per share, for a total transaction of £150.72.
- On Friday, September 4th, Nick Keher purchased 15,325 shares of Oxford Nanopore Technologies stock. The shares were acquired at an average price of GBX 162 per share, with a total value of £24,826.50.
- On Wednesday, August 12th, Nick Keher purchased 115 shares of Oxford Nanopore Technologies stock. The shares were acquired at an average price of GBX 131 per share, with a total value of £150.65.
Oxford Nanopore Technologies Stock Down 1.1%
Shares of LON:ONT opened at GBX 208.60 on Thursday. The business has a 50-day moving average price of GBX 171.33 and a 200 day moving average price of GBX 137.41. The company has a current ratio of 3.52, a quick ratio of 6.01 and a debt-to-equity ratio of 9.86. The company has a market capitalization of £2.04 billion, a price-to-earnings ratio of -16.69 and a beta of 0.87. Oxford Nanopore Technologies plc has a 12-month low of GBX 95.61 and a 12-month high of GBX 238.80.
Oxford Nanopore Technologies (LON:ONT - Get Free Report) last issued its quarterly earnings data on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative net margin of 54.66% and a negative return on equity of 35.45%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. boosted their price target on shares of Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the company an "overweight" rating in a research note on Thursday, August 27th. Peel Hunt restated a "hold" rating and issued a GBX 153 price objective on shares of Oxford Nanopore Technologies in a report on Monday, July 13th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 195 price objective on shares of Oxford Nanopore Technologies in a research report on Thursday, August 20th. Citigroup lowered Oxford Nanopore Technologies to a "buy" rating in a research report on Monday, July 20th. Finally, Berenberg Bank decreased their price target on Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a "buy" rating on the stock in a research note on Wednesday, August 19th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of GBX 198.60.
View Our Latest Stock Report on ONT
Oxford Nanopore Technologies Company Profile
(
Get Free Report)
Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
